A citation-based method for searching scientific literature


List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
22

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
22

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.
Kokichi Sugano, Seigo Nakamura, Jiro Ando, Shin Takayama, Hiroyuki Kamata, Isao Sekiguchi, Megumi Ubukata, Tetsuro Kodama, Masami Arai, Fujio Kasumi,[...]. Cancer Sci 2008
56
22

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Stephanie L Wethington, Kay J Park, Robert A Soslow, Noah D Kauff, Carol L Brown, Fanny Dao, Ebunoluwa Otegbeye, Yukio Sonoda, Nadeem R Abu-Rustum, Richard R Barakat,[...]. Int J Gynecol Cancer 2013
64
11

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
Joseph W Carlson, Alexander Miron, Elke A Jarboe, Mana M Parast, Michelle S Hirsch, Yonghee Lee, Michael G Muto, David Kindelberger, Christopher P Crum. J Clin Oncol 2008
238
11

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
562
11

Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.
Daichi Maeda, Satoshi Ota, Yutaka Takazawa, Kenichi Ohashi, Masaya Mori, Tetsuo Imamura, Shunsuke Nakagawa, Tetsu Yano, Yuji Taketani, Masashi Fukayama. Virchows Arch 2010
21
11

Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
Akira Hirasawa, Kenta Masuda, Tomoko Akahane, Tomohiko Tsuruta, Kouji Banno, Kazuya Makita, Nobuyuki Susumu, Hiromitsu Jinno, Yuko Kitagawa, Kokichi Sugano,[...]. Jpn J Clin Oncol 2013
9
11

Management of genetic syndromes predisposing to gynecologic cancers.
Susan Miesfeldt, Amanda Lamb, Christine Duarte. Curr Treat Options Oncol 2013
5
20

Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.
Akira Hirasawa, Kenta Masuda, Tomoko Akahane, Arisa Ueki, Megumi Yokota, Tomohiko Tsuruta, Hiroyuki Nomura, Fumio Kataoka, Eiichiro Tominaga, Kouji Banno,[...]. Jpn J Clin Oncol 2014
7
14

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Russell Vang, Ie-Ming Shih, Robert J Kurman. Histopathology 2013
165
11


Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
861
11

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
553
11

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Julie D Lamb, Rochelle L Garcia, Barbara A Goff, Pamela J Paley, Elizabeth M Swisher. Am J Obstet Gynecol 2006
65
11


Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
R Manchanda, A Abdelraheim, M Johnson, A N Rosenthal, E Benjamin, C Brunell, M Burnell, L Side, S Gessler, E Saridogan,[...]. BJOG 2011
72
11

Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.
Thaddeus Judkins, Brant C Hendrickson, Amie M Deffenbaugh, Kristilyn Eliason, Benoît Leclair, Michael J Norton, Brian E Ward, Dmitri Pruss, Thomas Scholl. Cancer Res 2005
49
11

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
72
11

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
Dana Meaney-Delman, Cecelia A Bellcross. Obstet Gynecol Clin North Am 2013
5
20

Development of an integrated support system for hereditary cancer and its impact on gynecologic services.
Mina Morii-Kashima, Hiroshi Tsubamoto, Chika Sato, Mariko Ushioda, Naohiro Tomita, Yasuo Miyoshi, Tomoko Hashimoto-Tamaoki, Kazuo Tamura, Hideaki Sawai, Hiroaki Shibahara. Int J Clin Oncol 2014
2
50

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
Marcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, Jill E Stopfer, Katherine L Nathanson, Barbara L Weber. J Natl Cancer Inst 2002
454
11

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
384
11

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
210
11

Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach.
Akiko Horiuchi, Kazuko Itoh, Motohiko Shimizu, Ikuko Nakai, Teruyuki Yamazaki, Kaoru Kimura, Akihiko Suzuki, Isao Shiozawa, Noritane Ueda, Ikuo Konishi. Gynecol Oncol 2003
66
11

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
361
11

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Noah D Kauff, Ilana Cass, Lee-May Chen, Karen H Lu, David G Mutch, Andrew Berchuck, Beth Y Karlan, Thomas J Herzog. Gynecol Oncol 2007
174
11

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
706
11


Clinical practice. Screening for ovarian cancer.
Daniel L Clarke-Pearson. N Engl J Med 2009
228
11

Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer.
Gabriella Pichert, Daniel Dietrich, Peter Moosmann, Marcel Zwahlen, Rolf Arno Stahel, André-Pascal Sappino. Fam Cancer 2003
25
11

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
Shilpa Grover, Elena M Stoffel, Laoti Bussone, Elizabeth Tschoegl, Sapna Syngal. Clin Gastroenterol Hepatol 2004
120
11

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
112
11

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
11

The use by Alabama pediatricians of genetics consultation in the evaluation of developmental delay.
Min-Jye Chen, Cheryl L Holt, Edward J Lose, Nathaniel H Robin. Am J Med Genet A 2008
7
14


Referral for genetic counselling during pregnancy: limited alertness and awareness about genetic risk factors among GPs.
Cora M Aalfs, Ellen M A Smets, Hanneke C J M de Haes, Nico J Leschot. Fam Pract 2003
26
11

GPs' opinions of their role in prenatal genetic services: a cross-sectional survey.
Nadeem Qureshi, Sarah Armstrong, Bernadette Modell. Fam Pract 2006
22
11

Clinical genetics issues encountered by family physicians.
Louise S Acheson, Kurt C Stange, Stephen Zyzanski. Genet Med 2005
42
11

Genetic counseling training and certification in Australasia.
A R McEwen, M A Young, S A Wake. J Genet Couns 2013
9
11

Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.
Edenir Inez Palmero, Patricia Ashton-Prolla, José Cláudio C da Rocha, Fernando Regla Vargas, Luciane Kalakun, Melissa Brauner Blom, Sérgio J Azevedo, Maira Caleffi, Roberto Giugliani, Lavinia Schüler-Faccini. J Genet Couns 2007
17
11


Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location.
Christine E Koil, Jessica N Everett, Leah Hoechstetter, Rick E Ricer, Karen M Huelsman. Genet Med 2003
34
11

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
61
11

Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
Anita Yeomans Kinney, Amanda Gammon, James Coxworth, Sara E Simonsen, Maritza Arce-Laretta. Genet Med 2010
63
11

Barriers to access: results from focus groups to identify genetic service needs in the community.
Rosalyn Y Beene-Harris, Catharine Wang, Janice V Bach. Community Genet 2007
22
11



Genetic competencies essential for health care professionals in primary care.
Janet L Engstrom, Marlene G S Sefton, Jolie Kim Matheson, Kristine M Healy. J Midwifery Womens Health 2005
8
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.